Overbrook Management Corp’s Bristol-Myers Squibb BMY Stock Holding History

Overbrook Management Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,290	Closed	-$271K	–	61
2023 Q4	$271K	Hold	5,290	–	–	0.05%	57
2023 Q3	$307K	Sell	5,290 -50	-0.9%	-$3.06K	0.07%	52
2023 Q2	$341K	Sell	5,340 -400	-7%	-$26.8K	0.08%	51
2023 Q1	$398K	Hold	5,740	–	–	0.1%	51
2022 Q4	$413K	Hold	5,740	–	–	0.12%	52
2022 Q3	$408K	Hold	5,740	–	–	0.12%	48
2022 Q2	$442K	Hold	5,740	–	–	0.13%	54
2022 Q1	$419K	Hold	5,740	–	–	0.09%	64
2021 Q4	$358K	Hold	5,740	–	–	0.07%	79
2021 Q3	$340K	Sell	5,740 -750	-12%	-$49.4K	0.07%	69
2021 Q2	$434K	Sell	6,490 -18	-0.3%	-$1.17K	0.09%	61
2021 Q1	$411K	Sell	6,508 -890	-12%	-$55.4K	0.09%	62
2020 Q4	$459K	Hold	7,398	–	–	0.11%	59
2020 Q3	$446K	Sell	7,398 -420	-5%	-$25.3K	0.1%	80
2020 Q2	$460K	Hold	7,818	–	–	0.12%	81
2020 Q1	$436K	Hold	7,818	–	–	0.2%	49
2019 Q4	$502K	Sell	7,818 -472	-6%	-$27K	0.15%	53
2019 Q3	$420K	Hold	8,290	–	–	0.11%	56
2019 Q2	$376K	Sell	8,290 -150	-2%	-$6.99K	0.08%	60
2019 Q1	$403K	Sell	8,440 -240	-3%	-$12K	0.09%	57
2018 Q4	$451K	Sell	8,680 -1,100	-11%	-$59.1K	0.11%	56
2018 Q3	$607K	Sell	9,780 -600	-6%	-$35.6K	0.12%	56
2018 Q2	$574K	Sell	10,380 -100	-1%	-$5.4K	0.11%	55
2018 Q1	$663K	Sell	10,480 -4,950	-32%	-$318K	0.14%	54
2017 Q4	$946K	Sell	15,430 -770	-5%	-$48.2K	0.19%	46
2017 Q3	$1.03M	Sell	16,200 -100	-0.6%	-$5.84K	0.23%	40
2017 Q2	$908K	Buy	16,300 +350	+2%	+$19K	0.2%	46
2017 Q1	$867K	Sell	15,950 -550	-3%	-$30.2K	0.19%	45
2016 Q4	$964K	Sell	16,500 -55	-0.3%	-$3.01K	0.21%	49
2016 Q3	$893K	Buy	16,555 +7,695	+87%	+$494K	0.21%	48
2016 Q2	$652K	Sell	8,860 -230	-3%	-$16.3K	0.14%	54
2016 Q1	$581K	Sell	9,090 -540	-6%	-$34.1K	0.13%	56
2015 Q4	$662K	Buy	9,630 +2,500	+35%	+$165K	0.12%	56
2015 Q3	$422K	Buy	7,130 +540	+8%	+$34.3K	0.07%	72
2015 Q2	$438K	Hold	6,590	–	–	0.07%	76
2015 Q1	$425K	Hold	6,590	–	–	0.07%	73
2014 Q4	$389K	Hold	6,590	–	–	0.08%	65
2014 Q3	$337K	Hold	6,590	–	–	0.05%	79
2014 Q2	$320K	Hold	6,590	–	–	0.06%	69
2014 Q1	$342K	Hold	6,590	–	–	0.07%	74
2013 Q4	$350K	Hold	6,590	–	–	0.07%	74
2013 Q3	$305K	Hold	6,590	–	–	0.07%	72
2013 Q2	$295K	Buy	+6,590	New	+$286K	0.07%	74

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Overbrook Management Corp's BMY Position: Q1 2024 in Review

Overbrook Management Corp sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 5,290 shares — an estimated $271K sold.

Overbrook Management Corp first reported a position in BMY in Q2 2013 and held it in 43 quarters. The position peaked at $1.03M in Q3 2017. 2,338 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Overbrook Management Corp reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Overbrook Management Corp sold 5,290 Bristol-Myers Squibb shares in Q1 2024, an estimated $271K.
Overbrook Management Corp first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 43 quarters.
Overbrook Management Corp's Bristol-Myers Squibb position peaked at $1.03M in Q3 2017.
2,338 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Overbrook Management Corp's 13F filing for Q1 2024, filed 16 Apr 2024.